Our analysis found that HCPs reacted as positively to the other two most-discussed lung cancer trials at ASCO 2024 - ADRIATIC ...

As Phil Taylor reported, this morning, the Association of the British Pharmaceutical Industry (ABPI) released its comments on ...

Boehringer filed its challenge last August after it became clear that its big-selling diabetes treatment Jardiance ...

Researchers from Harvard and Brigham and Women’s Hospital in Boston found an elevated risk with semaglutide of a condition ...

Just like people, no two cancer cells are alike. And now, scientists from the University of Surrey and SCIEX have come ...

This time last year, Pieris also lost a partnership with AstraZeneca on respiratory drug candidate elarekibep, one of up to ...

While the headlines are all about the Labour landslide in the UK general election this morning, Wes Streeting, who has been ...

About Aktiia - A vehicle for discovery in blood pressure Aktiia was founded in Switzerland in May 2018 from a passion to ...

The Series B – led by Forbion and joined by other investors, including Syncona, Oxford Science Enterprises, and Oxford ...

In the language of immuno-oncology (IO), the terms “hot” and “cold” refer to tumours that are inflamed or non-inflamed, ...

NeuroSense said that ALSFRS-R is the current “gold-standard” scale used in ALS drug development and the new data highlights ...

The European Commission has become the first regulator worldwide to approve Sanofi and Regeneron’s IL-4 and IL-13 inhibitor ...